Allergan (AGN) Tops Q4 EPS by 65c

February 10, 2020 7:03 AM EST

Allergan (NYSE: AGN) reported Q4 EPS of $5.22, $0.65 better than the analyst estimate of $4.57. Revenue for the quarter came in at $4.35 billion versus the consensus estimate of $4.09 billion.

For earnings history and earnings-related data on Allergan (AGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings